Business
Currency:USD
2023/FY
Stock NameRevenueRatio
Research and development of precision immuno-oncology agents for the treatment of cancer632K100.00%
Region
Currency:USD
2023/FY
Stock NameRevenueRatio
People's Republic of China3.9M100.00%